• Skip to primary navigation
  • Skip to main content
  • Skip to footer

HepVu

HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

  • INTERACTIVE MAP
  • Location Profiles
  • Find Services
  • News & Updates
  • Events
  • Tools & Resources
Home Vu Q&A Page 3

Vu Q&A

April 5, 2022

Leading Viral Hepatitis Groups Launch the Hep ElimiNATION Project

March 21, 2022

Combatting Hepatitis C Among People Who Use Drugs in Appalachia

Read More

March 21, 2022

Dr. John W. Ward on the Coalition for Global Hepatitis Elimination (CGHE)

Read More

November 18, 2021

Dr. Philip Spradling on the Hepatitis B Care Cascade

Read More

November 3, 2021

Dr. Samuel So on Liver Cancer & Hepatitis B and C

Read More

August 23, 2021

Dr. Eric Hall on County-Level Opioid Prescribing and Overdose Mortality Rates

Read More

July 28, 2021

U.S. Congresswoman Grace Meng on Funding Viral Hepatitis Surveillance and the Congressional Hepatitis Caucus

Read More

July 28, 2021

Jim Macrae on Health Disparities in Viral Hepatitis Elimination

Read More

May 25, 2021

APIAHF on HIV and Viral Hepatitis in the AANHPI Community

Read More

March 3, 2021

Dr. Eric Hall on County-Level Hepatitis C-Related Mortality Trends in the U.S.

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5

Sign up for HepVu updates.

Footer

AIDSVu HepVu

HepVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc.

  • About
  • FAQ
  • Data Methods
  • Datasets

Questions?
Info@HepVu.org

Media Inquiries
(202) 854-0480
Media@HepVu.org

Follow Us

  • Facebook
  • Twitter

© 2025 HepVu. All Rights Reserved.

  • Privacy Policy
  • Contact Us

Get HepVu in Your Inbox

Sign up to stay informed on new data, maps, expert Q&As, and infographics about Hepatitis C and opioids where you live.